Name: India Hospital Chains & Medical Tourism Market Study 2026–2031
Brand: eFinancialModels
SKU: 640562
Availability: InStock

Hero banner: modern hospital exterior with Akashay Hospital sign, overlaid title 'India Healthcare & Hospital Market Study 2026-2031' for eFinancialModels.

Financial Model, Health Care

Financial Modeling, Financial Planning, Free Financial Model Templates, Market Studies, PDF

India’s organized hospital-chain sector is one of Asia’s most investable healthcare opportunities. This 32-page study sizes the market, maps the structural bed shortage, profiles the leading chains (Apollo, Fortis, Max, Manipal, Narayana, Aster, Medanta), and quantifies the inbound medical-tourism opportunity — all through an institutional-investor lens.

Key findings

India’s hospital services market is estimated at roughly USD 119 billion in 2025, growing to a base-case USD 213 billion by 2031 at about 10% annually.
At roughly 1.3 beds per 1,000 people (total) versus a WHO reference of 3.5, India is structurally short of beds; about 65% of capacity sits in Tier-1 metros, making Tier-2/3 the build-out frontier.
Organized corporate chains hold only an estimated 15–20% of private-hospital revenue, leaving a long consolidation runway.
Max leads on revenue intensity at roughly INR 2.84 crore ARPOB per bed per year, ahead of Fortis (~2.51) and Apollo (~2.21).
Inbound medical tourism is estimated at roughly USD 9–12 billion in 2025, growing to a base-case USD 22 billion by 2031, led by Bangladesh, the Middle East and Africa.
Private equity has invested roughly USD 15.5 billion in Indian healthcare over five years; Temasek, Blackstone, KKR and TPG are building national platforms via control deals.

What’s inside

Market sizing and 2026–2031 trajectory (Section 2)
Supply-side bed-gap analysis and chain expansion pipeline (Section 3)
Demand drivers: insurance, PM-JAY, disease burden, medical tourism (Section 4)
Pricing, ARPOB and EV/EBITDA valuation dynamics (Section 5)
Three probability-weighted 2031 scenarios (Section 6)
Technology, accreditation and the medical-tourism engine (Section 7)
Regulatory and policy context, including price-control risk (Section 8)
Competitive landscape and PE/M&A map (Section 9)

Data and sources

Built from 34+ verified sources: TechSci, IMARC, Mordor, KPMG, EY-Parthenon, IBEF, company FY25 filings, and Government of India data. Every chart and table carries a specific source line; a companion source-verification workbook documents each citation.

Who it’s for

Private equity, hospital REITs/InvITs, strategic acquirers, equity analysts, chain operators planning expansion, and medical-tourism payers.

Methodology

eFinancialModels uses AI-assisted research and drafting tools alongside human research, source verification and editorial review. Every claim, statistic, source, chart, and recommendation was reviewed and verified before publication. Forward-looking figures are labelled and reflect analyst judgment.